Cybin (CYBN) Stock: Buy, Sell, or Hold?
$8.28
+0.10 (+1.22%)
â˛
5d:
+0.85%
30d:
+50.27%
90d:
+33.33%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (82%)
Quality Score
39/100
Position
FAIR
Forward P/E & Valuation
-2.1x
Next 12M consensus est.
Wall Street Target
$48.00
+479.7% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$6.75 / $9.12
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CYBN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CYBN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CYBN is currently trading at $8.28, which is considered fair based on recent price action.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
39/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
Trading Range & Key Levels
Support Level
$6.75
Resistance Level
$9.12
Current Trend
Sideways
Technical data as of
Jan 2, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 479.7% below Wall St target ($48.00)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$48.00
(+479.7%)
Share CYBN Analysis
Share this live CYBN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CYBN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jan 3, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user expresses interest in $CYBN, viewing it as a potential idiosyncratic play in the disruption of the anxiety and MDD market.
Key Retail Themes:
potential disruption in the anxiety and MDD market
interest in $CYBN as an idiosyncratic play
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:48 AM ET
Data refreshes hourly during market hours. Next update: 10:48 AM
Data refreshes hourly during market hours. Next update: 10:48 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYBN showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
PALI
Palisade Bio Inc |
STRONG BUY
10 analysts |
$10 | 62 BUY |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CYBN Research Pages
